Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
21.48
+0.33 (1.56%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Biohaven Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Biohaven stock have an average target of 63.15, with a low estimate of 54 and a high estimate of 76. The average target predicts an increase of 193.99% from the current stock price of 21.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 7, 2025.
Analyst Ratings
The average analyst rating for Biohaven stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 6 | 6 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $69 → $63 | Buy | Maintains | $69 → $63 | +193.30% | Mar 7, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $72 → $68 | Buy | Maintains | $72 → $68 | +216.57% | Mar 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $54 | Strong Buy | Reiterates | $54 | +151.40% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +183.99% | Mar 4, 2025 |
| Deutsche Bank | Deutsche Bank | Strong Buy Initiates $65 | Strong Buy | Initiates | $65 | +202.61% | Feb 11, 2025 |
Financial Forecast
Revenue This Year
852.00M
from 852.00M
Revenue Next Year
1.41B
from 852.00M
Increased by 65.26%
EPS This Year
-6.96
from -9.28
EPS Next Year
-5.95
from -6.96
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 60.9M | 186.9M | 899.3M | ||
| Avg | 24.0M | 115.3M | 495.2M | ||
| Low | n/a | n/a | 200.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -92.9% | 679.3% | 679.9% | ||
| Avg | -97.2% | 380.7% | 329.4% | ||
| Low | - | - | 74.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.25 | -4.13 | -3.86 | ||
| Avg | -6.96 | -5.95 | -4.30 | ||
| Low | -9.44 | -9.01 | -4.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.